Predictive factors of pathologic complete response of HER2-positive breast cancer after preoperative chemotherapy with trastuzumab: development of a specific predictor and study of its utilities using decision curve analysis.
Breast Cancer Res Treat
; 161(1): 73-81, 2017 01.
Article
en En
| MEDLINE
| ID: mdl-27807808
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Neoplasias de la Mama
/
Cuidados Preoperatorios
/
Trastuzumab
/
Antineoplásicos Inmunológicos
Tipo de estudio:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Breast Cancer Res Treat
Año:
2017
Tipo del documento:
Article